Well Told Grants

Grants / Department of Health and Human Services / National Institutes of Health

RFA-CA-22-036: NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Required)

Closed Closed February 28, 2023 Opportunity RFA-CA-22-036

This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of National Institutes of Health notices from 2022.

National Institutes of Health offered grants to nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. Applications closed on February 28, 2023.

From the official notice on Grants.gov, last changed September 15, 2022. Checked November 7, 2026.

About this NIH notice

Projects funded under RFA-CA-22-036 were run by National Cancer Institute (NCI, 4 projects). Contact the program officer at the institute that fits your project before you apply; the notice lists them.

Application due dates, page limits and budget limits are set in the notice. Read RFA-CA-22-036 in the NIH Guide.

Other notices with this title

National Institutes of Health has posted this title under other numbers: earlier or later rounds, or the same competition for another area. Each has its own dates and may change its rules.

NoticePostedDeadlineStatus
RFA-CA-21-061November 5, 2021Closed February 28, 2022Closed

Key dates

PostedSeptember 15, 2022
DeadlineFebruary 28, 2023
Archived by Grants.govApril 5, 2023

Who can apply

This opportunity was open to nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses.

All 15 applicant types the notice lists

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

More grants for nonprofits, colleges and universities, state and local governments, tribes, small businesses, businesses.

Is this a realistic fit?

What the grant funds

The purpose of the NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00) program is to increase and maintain a strong cohort of new and talented, NCI-supported, independent investigators. This program is designed for postdoctoral fellows with research and/or clinical doctoral degrees who do not require an extended period of mentored research training beyond their doctoral degrees. The objective of this award is to facilitate a timely transition of these fellows from their mentored, postdoctoral research positions to independent tenure-track (or equivalent) faculty positions. The program will provide independent NCI research support during this transition to help awardees to launch competitive, independent research careers. Researchers in the scientific areas of data science and cancer control science are especially encouraged to apply. This Funding Opportunity Announcement (FOA) is designed specifically for candidates proposing to serve as the lead investigator of an independent clinical trial, a clinical trial feasibility study, or a separate ancillary clinical trial, as part of their research and career development. Those not planning an independent clinical trial, or proposing to gain research experience in a clinical trial led by another investigator, must apply to the companion FOAs (RFA-CA-22-035).

Category: Education, Health.

Funded under RFA-CA-22-036 so far

NIH funded 4 projects under RFA-CA-22-036 in fiscal 2024 to 2026, at 4 institutions. The median yearly award was $247,238.

From NIH RePORTER, which lists each project once per fiscal year it was funded. Amounts are the yearly award.

Who has won Cancer Research Manpower grants before

From fiscal 2021 to 2025, Cancer Research Manpower (93.398) awarded $1.0 billion across 2,913 grant awards, an average of $359,612 per award.

Largest recipients, fiscal 2021 to 2025
RecipientStateAwardsAmount
Sloan-Kettering Institute for Cancer ResearchNew York92$52.8 million
Dana-Farber Cancer Institute, Inc.Massachusetts100$38.4 million
The Univeristy of Texas M.D. Anderson Cancer CenterTexas65$35.5 million
The General Hospital CorporationMassachusetts58$35.4 million
The Johns Hopkins UniversityMaryland69$33.7 million

Top states: New York ($140 million), California ($138 million), Massachusetts ($127 million), Texas ($62.2 million), Pennsylvania ($52.9 million).

Applying now

This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.

The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.

Questions people ask

Is RFA-CA-22-036 still open?

No. It closed on February 28, 2023.

Who can apply for NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Required)?

National Institutes of Health accepted applications from nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. The notice adds further conditions, so read its eligibility section.

What is the deadline for NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Required)?

Closed February 28, 2023. Applications are no longer accepted; the program's newer notices are on this page when there are any.

Who has been funded under RFA-CA-22-036?

NIH RePORTER lists 4 projects funded under RFA-CA-22-036 in fiscal 2024 to 2026, at 4 institutions. The most were at Medical University of South Carolina, Fred Hutchinson Cancer Center, Dana-Farber Cancer Inst.

Who has won Cancer Research Manpower grants before?

The largest recipients over five fiscal years were Sloan-Kettering Institute for Cancer Research, Dana-Farber Cancer Institute, Inc., The Univeristy of Texas M.D. Anderson Cancer Center. The program made 2,913 awards worth $1.0 billion in that time.

Similar open grants